Strategy Training and Pets to Promote Stroke Survivor's Cognitive Performance and Community Participation

August 6, 2024 updated by: Naor Demeter, University of Haifa
The study will administer an intervention called strategy training to adult stroke survivors living in the community who do and do not have pets, and will examine the role of a pet in promoting cognitive performance and community participation outcomes.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15219
        • University of Pittsburgh
        • Contact:
          • Minmei Shih, PhD, OTR/L
          • Phone Number: 412-383-6752
          • Email: mis235@pitt.edu
        • Contact:
          • Elizabeth R Skidmore, PhD, OTR/L
          • Phone Number: (412) 383-6617
          • Email: skidmore@pitt.edu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Stroke survivors with pets

Inclusion Criteria:

  1. Primary diagnosis of acute stroke
  2. At least 3 months after the stroke onset
  3. Living in a community residence with a pet
  4. Cognitive impairment as indicated by an Executive Interview score of 3 or higher
  5. Participation restrictions as indicated by an Activity Card Sort (<80% of pre-stroke activities)
  6. Willing to participate in a 6-week program with 2 intervention sessions per week at home

Exclusion Criteria:

  1. Dementia as indicated by Montreal Cognitive Assessment score of 18 or lower
  2. Severe aphasia as indicated by the Boston Diagnostic Aphasia Examination Severity Score of 0 or 1
  3. Self-report of a central nervous system disorder other than stroke
  4. Recent drug or alcohol addiction/abuse within 3 months prior to the Mini-Neuropsychiatric Interview
  5. Severe mental illness as indicated by the PRIME-MD
  6. Prior exposure to strategy training
  7. Currently participate in rehabilitation therapy programs

Stroke survivors without pets

Inclusion Criteria:

  1. Primary diagnosis of acute stroke
  2. At least 3 months after the stroke onset
  3. Living in a community residence
  4. Cognitive impairment as indicated by an Executive Interview score of 3 or higher
  5. Participation restrictions as indicated by an Activity Card Sort (<80% of pre-stroke activities)
  6. Willing to participate in a 6-week program with 2 intervention sessions per week at home

Exclusion Criteria:

  1. Dementia as indicated by Montreal Cognitive Assessment score of 18 or lower
  2. Severe aphasia as indicated by the Boston Diagnostic Aphasia Examination Severity Score of 0 or 1
  3. Self-report of a central nervous system disorder other than stroke
  4. Recent drug or alcohol addiction/abuse within 3 months prior to the Mini-Neuropsychiatric Interview
  5. Severe mental illness as indicated by the PRIME-MD
  6. Prior exposure to strategy training
  7. Currently participate in rehabilitation therapy programs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stroke survivors with pets
Stroke survivors with pets will receive strategy training for 10-15 sessions, 45 minutes each session, delivered by a trained occupational therapist in the home.
Strategy training is comprised of participant-selected activity based goals, self evaluation, global problem solving strategies, and therapist-delivered guided training. The strategy training therapist will guide participants using prompting questions, as well as work sheets that facilitate learning and aid the participants in implementing the process.
Active Comparator: Stroke survivors without pets
Stroke survivors without pets will receive strategy training for 10-15 sessions, 45 minutes each session, delivered by a trained occupational therapist in the home.
Strategy training is comprised of participant-selected activity based goals, self evaluation, global problem solving strategies, and therapist-delivered guided training. The strategy training therapist will guide participants using prompting questions, as well as work sheets that facilitate learning and aid the participants in implementing the process.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean engagement score as measured by the Pittsburgh Rehabilitation Participation Scale
Time Frame: Baseline to 6 weeks
The scale is a valid and reliable criterion referenced measure that assesses engagement in rehabilitation therapy sessions. Each session is scored by the occupational therapist, 1 (no participation, refusal) to 6 (excellent participation). Scores are averaged across the 10-15 intervention sessions to generate the mean engagement score.
Baseline to 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in attention as measured by the Color Trail Test 1
Time Frame: Baseline to 3 months
This measure assesses perceptual tracking, sustained attention and grapho-motor skills. It is a pencil and paper, timed test. Completion time in seconds for each task is recorded, with a lower score representing better function. Change in attention will be calculated by subtracting the time to do the task at baseline from the time to do the task at 3 months.
Baseline to 3 months
Change in executive function as measured by the Color Trail Test 2
Time Frame: Baseline to 3 months
This measure assesses divided attention and sequencing skills, which are executive function performance. It is a pencil and paper, timed test of effortful executive processing abilities that assesses the ability to alternate between two colors. Completion time in seconds for each task is recorded, with a lower score representing better function. Change in executive function will be calculated by subtracting the time to do the task at baseline from the time to do the task at 3 months.
Baseline to 3 months
Change in community participation as measure by Community Participation Indicators score
Time Frame: Baseline to 3 months
This participant reported questionnaire will measure the frequency of community participation over a 7 days period. Each item is measured on a 5-point Likert scale, with 1=no participation in that activity and 5=7 days of participation in that activity. A total of 20 items are summed to yield a total score. Change in community participation will be calculated by subtracting baseline total score from the 3 month total score.
Baseline to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Naor Domotor, PhD, University of Pittsburgh

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2024

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

October 15, 2021

First Submitted That Met QC Criteria

October 15, 2021

First Posted (Actual)

October 28, 2021

Study Record Updates

Last Update Posted (Actual)

August 9, 2024

Last Update Submitted That Met QC Criteria

August 6, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Strategy Training

Subscribe